Detection of porcine endogenous retrovirus in xenotransplantation

Reproductive Biology

Volumn 14, Issue 1, 2014, Pages 68-73

  Gola, Joanna ^a   Mazurek, Urszula ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Infectivity assays; PERV detection methods; Porcine endogenous retroviruses (PERVs); Real time PCR; Real time RT PCR; Xenotransplantation

Indexed keywords

ANIMAL; ENDOGENOUS RETROVIRUS; HUMAN; INFECTIVITY ASSAYS; ISOLATION AND PURIFICATION; PERV DETECTION METHODS; PORCINE ENDOGENOUS RETROVIRUSES (PERVS); REAL-TIME PCR; REAL-TIME RT-PCR; REVIEW; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

INFECTIVITY ASSAYS; PERV DETECTION METHODS; PORCINE ENDOGENOUS RETROVIRUSES (PERVS); REAL-TIME PCR; REAL-TIME RT-PCR; XENOTRANSPLANTATION;

ANIMALS; ENDOGENOUS RETROVIRUSES; HUMANS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84897673203     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2014.01.006     Document Type: Review

References (59)

1. Lechler R.I., Sykes M., Thomson A.W., Turka L.A. Organ transplantation-how much of the promise has been realized?. Nat Med 2005, 11:605-613.
2. Salim A., Martin M., Brown C., Rhee P., Demetriades D., Belzberg H. The effect of a protocol of aggressive donor management: implications for the national organ donor shortage. J Trauma 2006, 61:429-435.
3. Fiorelli A.I., Stolf N.A., Pego-Fernandes P.M., Oliveira Junior J.L., Santos R.H., Contreras C.A., et al. Recommendations for use of marginal donors in heart transplantation: Brazilian Association of Organs Transplantation guideline. Transplant Proc 2011, 43:211-215.
4. PHS guideline on infectious disease issues in xenotransplantation. ; January 19, 2001. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Xenotransplantation/UCM092858.pdf.
5. Jasinski A., Slomski R., Szalata M., Lipinski D. The organ transplantation-a challenge for biotechnology. Biotechnologia 2006, 72:7-28.
6. Cozzi E., Bosio E., Seveso M., Rubello D., Ancona E. Xenotransplantation as a model of integrated, multidisciplinary research. Organogenesis 2008, 5:288-296.
7. Denner J., Tönjes R.R. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev 2012, 25(2):318-343.
8. Cooper D.K. A brief history of cross-species organ transplantation. Proc (Bayl Univ Med Cent) 2012, 25:49-57.
9. Denner J. Infectious risk in xenotransplantation-what post-transplant screening for the human recipient?. Xenotransplantation 2011, 18(3):151-157.
10. Denner J., Schuurman H.J., Patience C. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes. Chapter 5. Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009, 16(4):239-248.
11. Denner J. Is porcine endogenous retrovirus (PERV) transmission still relevant?. Transplant Proc 2008, 40:587-589.
12. Löwer R., Löwer J., Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996, 93:5177-5184.
13. Liu G., Li Z., Pan M., Ge M., Wang Y., Gao Y. Genetic prevalence of porcine endogenous retrovirus in Chinese experimental miniature pigs. Transplant Proc 2011, 43:2762-2769.
14. Takeuchi Y., Patience C., Magre S., Weiss R.A., Banerjee P.T., Le Tissier P., et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998, 72:9986-9991.
15. Bartosch B., Stefanidis D., Myers R., Weiss R., Patience C., Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 2004, 78:13880-13890.
16. Pal N., Baker R., Schalk S., Scobie L., Tucker A.W., Opriessnig T. Detection of porcine endogenous retrovirus (PERV) viremia in diseased versus healthy US pigs by qualitative and quantitative real-time RT-PCR. Transbound Emerg Dis 2011, 58(4):344-351.
17. Mazurek U., Kimsa M.C., Strzalka-Mrozik B., Kimsa M.W., Adamska J., Lipinski D., et al. Quantitative analysis of porcine endogenous retroviruses in different organs of transgenic pigs generated for xenotransplantation. Curr Microbiol 2013, 67(4):505-514.
18. Lavillette D., Kabat D. Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol 2004, 78(16):8868-8877.
19. Gemeniano M., Mpanju O., Salomon D.R., Eiden M.V., Wilson C.A. The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-terminal region of its surface envelope protein. Virology 2006, 346(1):108-117.
20. Harrison I., Takeuchi Y., Bartosch B., Stoye J.P. Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol 2004, 78:13871-13879.
21. Wilson C.A., Wong S., VanBrocklin M., Federspiel M.J. Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 2000, 74:49-56.
22. Wood J.C., Quinn G., Suling K.M., Oldmixon B.A., Van Tine B.A., Cina R., et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004, 78(5):2494-2501.
23. Wood A., Webb B.L., Bartosch B., Schaller T., Takeuchi Y., Towers G.J. Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol 2009, 90:702-709.
24. Denner J., Specke V., Thiesen U., Karlas A., Kurth R. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus (PERV) during passage in human cells. Virology 2003, 314:125-133.
25. Kaulitz D., Mihica D., Plesker R., Geissler A., Tönjes R.R., Denner J. Absence of infection in pigs inoculated with high-titre recombinant PERV-A/C. Arch Virol 2011, 156(4):707-710.
26. Kaulitz D., Mihica D., Dorna J., Costa M.R., Petersen B., Niemann H., et al. Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs. J Virol Methods 2011, 175(1):60-65.
27. Moon H.J., Park S.J., Kim H.K., Ann S.K., Rho S., Keum H.O., et al. Simultaneous detection and subtyping of porcine endogenous retroviruses proviral DNA using the dual priming oligonucleotide system. J Vet Sci 2010, 11(3):269-271.
28. Kaulitz D., Mihica D., Adlhoch C., Semaan M., Denner J. Improved pig donor screening including newly identified variants of porcine endogenous retrovirus-C (PERV-C). Arch Virol 2013, 158(2):341-348.
29. Sypniewski D., Machnik G., Mazurek U., Wilczok T., Smorag Z., Jura J., et al. Distribution of porcine endogenous retroviruses (PERVs) DNA in organs of a domestic pig. Ann Transplant 2005, 10(2):46-51.
30. Zhang P., Yu P., Wang W., Zhang L., Li S., Bu H. An effective method for the quantitative detection of porcine endogenous retrovirus in pig tissues. In Vitro Cell Dev Biol Anim 2010, 46(5):408-410.
31. Bittmann I., Mihica D., Plesker R., Denner J. Expression of porcine endogenous retroviruses (PERV) in different organs of a pig. Virology 2012, 433(2):329-336.
32. Moon H.J., Kim H.K., Park S.J., Lee C.S., Song D.S., Kang B.K., et al. Comparison of the age-related porcine endogenous retrovirus (PERV) expression using duplex RT-PCR. J Vet Sci 2009, 10(4):317-322.
33. Lipinski D., Jura J., Zeyland J., Juzwa W., Maly E., Kalak R., et al. Production of transgenic pigs expressing human a-1,2-fucosyltransferase to avoid humoral xenograft rejection. Med Weter 2010, 66(5):316-322.
34. Wieczorek J., Słomski R., Kowalski W., Smorag Z. Effect of genetic modification on the health status of transgenic pigs produced with the human α-1,2-fucosyltransferase gene. Med Weter 2011, 67:462-466.
35. Lipinski D., Zeyland J., Plawski A., Slomski R. Determination of the absolute number of transgene copies in CMVFUT transgenic pigs. Ann Anim Sci 2012, 12(3):349-356.
36. Dieckhoff B., Kessler B., Jobst D., Kues W., Petersen B., Pfeifer A., et al. Distribution and expression of porcine endogenous retroviruses in multi-transgenic pigs generated for xenotransplantation. Xenotransplantation 2009, 16(2):64-73.
37. Matousková M., Vesely P., Daniel P., Mattiuzzo G., Hector R.D., Scobie L., et al. Role of DNA methylation in expression and transmission of porcine endogenous retroviruses. J Virol 2013, 87(22):12110-12120.
38. Wolf G., Nielsen A.L., Mikkelsen J.G., Pedersen F.S. Epigenetic marking and repression of porcine endogenous retroviruses. J Gen Virol 2013, 94:960-970.
39. Nakaya Y., Shojima T., Yasuda J., Imakawa K., Miyazawa T. Epigenetic regulation on the 5'-proximal CpG island of human porcine endogenous retrovirus subgroup A receptor 2/GPR172B. Microbes Infect 2011, 13(1):49-57.
40. Moalic Y., Blanchard Y., Félix H., Jestin A. Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J Virol 2006, 80(22):10980-10988.
41. Prabha S.M., Verghese S. Transmission of zoonoses in xenotransplantation: porcine endogenous retroviruses from an immunological and molecular point of view. Indian J Med Sci 2012, 66(9-10):199-206.
42. Moalic Y., Félix H., Takeuchi Y., Jestin A., Blanchard Y. Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots. J Virol 2009, 83(4):1920-1929.
43. Clémenceau B., Jégou D., Martignat L., Saï P. Long-term follow-up failed to detect in vitro transmission of full-length porcine endogenous retroviruses from specific pathogen-free pig islets to human cells. Diabetologia 2001, 44(11):2044-2055.
44. Specke V., Rubant S., Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 2001, 285(2):177-180.
45. Gaur M., Leavitt A.D. Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J Virol 1998, 72:4678-4685.
46. Kimsa M., Strzalka-Mrozik B., Kimsa M., Adamska J., Gola J., Lopata K., et al. Quantitative estimation of porcine endogenous retrovirus release from PK15 cells. Pol J Microbiol 2012, 61(3):211-215.
47. Armstrong J.A., Porterfield J.S., De Madrid A.T. C-type virus particles in pig kidney cell lines. J Gen Virol 1971, 10(2):195-198.
48. Le Bas-Bernardet S., Tillou X., Poirier N., Dilek N., Chatelais M., Devallière J., et al. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons. Transplant Proc 2011, 43(9):3426-3430.
49. Mueller N.J., Takeuchi Y., Mattiuzzo G., Scobie L. Microbial safety in xenotransplantation. Curr Opin Organ Transplant 2011, 16(2):201-206.
50. Issa N.C., Wilkinson R.A., Griesemer A., Cooper D.K., Yamada K., Sachs D.H., et al. Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig-to-baboon xenotransplantation. J Virol 2008, 82(24):12441-12448.
51. Valdes-Gonzalez R., Dorantes L.M., Bracho-Blanchet E., Rodríguez-Ventura A., White D.J. No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation. J Med Virol 2010, 82(2):331-334.
52. Wynyard S., Garkavenko O., Elliot R. Multiplex high resolution melting assay for estimation of porcine endogenous retrovirus (PERV) relative gene dosage in pigs and detection of PERV infection in xenograft recipients. J Virol Methods 2011, 175(1):95-100.
53. Dinsmore J.H., Manhart C., Raineri R., Jacoby D.B., Moore A. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 2000, 70:1382-1389.
54. Fink J.S., Schumacher J.M., Ellias S.L., Palmer E.P., Saint-Hilaire M., Shannon K., et al. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant 2000, 9(2):273-278.
55. Yang Q., Liu F., Pan X.P., Lv G., Zhang A., Yu C.B., et al. Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission. Hepatol Int 2010, 4(4):757-761.
56. Shi X.L., Zhang Y., Chu X.H., Han B., Gu J.Y., Xiao J.Q., et al. Evaluation of a novel hybrid bioartificial liver based on a multi-layer flat-plate bioreactor. World J Gastroenterol 2012, 18(28):3752-3760.
57. Han B., Shi X.L., Zhang Y., Chu X.H., Gu J.Y., Xiao J.Q., et al. Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: an experimental study. Eur J Med Res 2012, 17:13.
58. Di Nicuolo G., D'Alessandro A., Andria B., Scuderi V., Scognamiglio M., Tammaro A., et al. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. Xenotransplantation 2010, 17(6):431-439.
59. Scobie L., Padler-Karavani V., Le Bas-Bernardet S., Crossan C., Blaha J., Matouskova M., et al. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol 2013, 191(6):2907-2915.